Atea Pharmaceuticals to Present Data on Bemnifosbuvir Drug
BOSTON, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage
Globe Newswire16-02-2023, 04:07
Teva Prolia® (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA 8-10-2024, 18:00